36C25026Q0828

Department of Veterans Affairs, Veterans Integrated Service Network 10, Cleveland Veterans Affairs Medical Center, is announcing its intent to sole-source one Scrambler Therapy ST-5A medical device from Delta International Services & Logistics, Inc. dba Erickson Strong Medical, with a September 2, 2026, 5:00 PM EST deadline for interested parties to submit capabilities information.

The Scrambler Therapy ST-5A is a patented, non-invasive, non-opioid pain management device manufactured exclusively in Italy by Delta International and distributed solely in the United States by the same company at 506 Honea Egypt Road, #960, Magnolia, Texas. The device employs Shannon information theory to deliver variable, non-repetitive synthetic signals for chronic and neuropathic pain management, with clinical validation from Mayo Clinic, Johns Hopkins University, and MD Anderson Cancer Center demonstrating 80–90% effectiveness and no significant adverse effects. Market research through a prior sources-sought notice (36C25026Q0070), GSA eLibrary, SAM.gov, FDA databases, and the Dynamic Small Business Search identified no alternative vendors capable of meeting requirements. The procurement is a firm-fixed-price purchase order with four-week delivery required after receipt of order; the vendor is a verified small business under NAICS 334519.

Interested parties must submit via email to Rachelle Hamer at rachelle.hamer@va.gov with subject line "RFQ 36C25026Q0828| Scrambler," providing authorized distributor letters, specifications, five-year pricing, SAM UEI number, delivery timeline, country of manufacture, and clarification of OEM or distributor status. The government reserves the right to conduct competitive procurement based on submitted capabilities.